RhythmAnalytics vs Fetal EchoScan
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
RhythmAnalytics focuses on AI-powered interpretation of cardiac arrhythmias from single-lead ECG data, providing decision support for a broad range of cardiac conditions. In contrast, Fetal EchoScan is an AI-powered ultrasound screening software specifically designed for the prenatal detection of congenital heart defects. While both tools utilize AI in cardiology and are FDA-cleared, their distinct data modalities (ECG vs. ultrasound) and target patient populations (general vs. fetal) make them suitable for different diagnostic applications.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
RhythmAnalytics by Biofourmis is an AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals. Fetal EchoScan by Brightheart is an FDA-cleared AI-powered ultrasound screening software that assists clinicians in the prenatal detection of congenital heart defects.
RhythmAnalytics analyzes single-lead ECG data from compatible FDA-cleared ECG devices such as Holter monitors, event recorders, or wearable sensors. Fetal EchoScan analyzes ultrasound data, specifically fetal ultrasound video clips, during prenatal examinations.
RhythmAnalytics is designed for Cardiology, Emergency Medicine, and Internal Medicine. Fetal EchoScan supports Cardiology, Maternal-Fetal Medicine, and Radiology.
RhythmAnalytics is a cloud-based API designed for integration with existing cardiac monitoring solutions or directly into medical devices or wearable sensors. Fetal EchoScan is a cloud-based software-only device that integrates seamlessly with existing ultrasound workflows, is DICOM compatible, and displays real-time AI analysis on a cart-side tablet.
Fetal EchoScan provides real-time guidance and feedback during ultrasound scans, with a cart-side tablet display for real-time AI analysis and alerts. RhythmAnalytics offers automated interpretation of ECG data, which can be integrated into existing cardiac monitoring solutions, supporting both real-time monitoring and post-processing depending on the integration with various ECG devices.
RhythmAnalytics detects over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats. Fetal EchoScan focuses on the automated detection of congenital heart defects (CHDs) and flags suspicious radiographic findings in the fetal heart.
RhythmAnalytics enhances clinical decision support for cardiac arrhythmias by providing AI-based automated interpretation, improving accuracy and scalability of ECG analysis. Fetal EchoScan optimizes workflow by ensuring exam completeness and standardization of fetal heart assessments, reducing false-negative and false-positive errors in CHD detection, and offering faster reading times.